Ellen Townley

708 total citations
12 papers, 399 citations indexed

About

Ellen Townley is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Ellen Townley has authored 12 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Epidemiology and 3 papers in Virology. Recurrent topics in Ellen Townley's work include HIV/AIDS drug development and treatment (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and HIV Research and Treatment (3 papers). Ellen Townley is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and HIV Research and Treatment (3 papers). Ellen Townley collaborates with scholars based in United States, South Africa and Zimbabwe. Ellen Townley's co-authors include Nomhle Khoza, Rhian Twine, Amanda Selin, Susan H. Eshleman, Chirayath Suchindran, Catherine MacPhail, Kathleen Kahn, Jing Wang, Audrey Pettifor and Ryan G. Wagner and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ellen Townley

11 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Townley United States 7 262 152 144 89 50 12 399
Boniphace S. Jullu Tanzania 8 231 0.9× 93 0.6× 175 1.2× 85 1.0× 60 1.2× 13 388
Nandita Sugandhi United States 13 352 1.3× 133 0.9× 165 1.1× 65 0.7× 88 1.8× 29 425
Maximillian Bweupe United States 11 254 1.0× 106 0.7× 224 1.6× 50 0.6× 114 2.3× 14 389
Gundo Weiler Switzerland 5 298 1.1× 145 1.0× 91 0.6× 32 0.4× 76 1.5× 8 434
Henry Irunde Tanzania 6 435 1.7× 186 1.2× 203 1.4× 58 0.7× 98 2.0× 7 532
Désiré Lucien Dahourou Burkina Faso 10 236 0.9× 67 0.4× 133 0.9× 21 0.2× 44 0.9× 44 320
Prosper Behumbiize Uganda 4 480 1.8× 206 1.4× 142 1.0× 36 0.4× 92 1.8× 8 539
Karusa Kiragu United States 9 264 1.0× 85 0.6× 252 1.8× 70 0.8× 112 2.2× 14 402
Sandy Pillay South Africa 14 257 1.0× 158 1.0× 180 1.3× 17 0.2× 36 0.7× 20 362
Brodie Daniels South Africa 9 224 0.9× 160 1.1× 151 1.0× 24 0.3× 32 0.6× 21 408

Countries citing papers authored by Ellen Townley

Since Specialization
Citations

This map shows the geographic impact of Ellen Townley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Townley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Townley more than expected).

Fields of papers citing papers by Ellen Townley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Townley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Townley. The network helps show where Ellen Townley may publish in the future.

Co-authorship network of co-authors of Ellen Townley

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Townley. A scholar is included among the top collaborators of Ellen Townley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Townley. Ellen Townley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Chandasana, Hardik, Ann M. Buchanan, Cynthia H. Brothers, et al.. (2024). Bridging dolutegravir clinical viral response across doses and formulations using model-based exposure–response analysis in pediatrics. AIDS. 38(9). F11–F18. 2 indexed citations
3.
Brown, Larry K., Kristin Baltrusaitis, Betsy D. Kennard, et al.. (2022). Forty-Eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth With HIV in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes. 91(3). 296–304. 2 indexed citations
4.
MacBrayne, Christine E., Richard M. Rutstein, Andrew Wiznia, et al.. (2021). Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age. AIDS. 35(9). 1413–1421. 2 indexed citations
5.
Mathad, Jyoti S., Rada Savic, Paula Britto, et al.. (2021). Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. Clinical Infectious Diseases. 74(9). 1604–1613. 22 indexed citations
6.
7.
Krogstad, Paul, Pearl Samson, Edward P. Acosta, et al.. (2020). Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. Journal of the Pediatric Infectious Diseases Society. 10(2). 201–204. 7 indexed citations
8.
Meyers, Tammy, Pearl Samson, Edward P. Acosta, et al.. (2019). Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2–12 years on rifampicin for tuberculosis. AIDS. 33(14). 2197–2203. 6 indexed citations
9.
Pettifor, Audrey, Catherine MacPhail, James P. Hughes, et al.. (2016). The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial. The Lancet Global Health. 4(12). e978–e988. 189 indexed citations
10.
Viani, Rolando M., Carmelita Alvero, Terry Fenton, et al.. (2015). Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents. The Pediatric Infectious Disease Journal. 34(11). 1207–1213. 40 indexed citations
11.
Groll, Andreas H., Lauren V. Wood, Maureen Roden, et al.. (2002). Safety, Pharmacokinetics, and Pharmacodynamics of Cyclodextrin Itraconazole in Pediatric Patients with Oropharyngeal Candidiasis. Antimicrobial Agents and Chemotherapy. 46(8). 2554–2563. 77 indexed citations
12.
Fischer, Steven H., Vee J. Gill, Joseph A. Kovacs, et al.. (2001). The Use of Oral Washes to DiagnosePneumocystis cariniiPneumonia: A Blinded Prospective Study Using a Polymerase Chain Reaction–Based Detection System. The Journal of Infectious Diseases. 184(11). 1485–1488. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Boniphace S. Jullu Breakdown of academic impact, for papers by Nandita Sugandhi Breakdown of academic impact, for papers by Maximillian Bweupe Breakdown of academic impact, for papers by Gundo Weiler Breakdown of academic impact, for papers by Henry Irunde Breakdown of academic impact, for papers by Désiré Lucien Dahourou Breakdown of academic impact, for papers by Prosper Behumbiize Breakdown of academic impact, for papers by Karusa Kiragu Breakdown of academic impact, for papers by Sandy Pillay Breakdown of academic impact, for papers by Brodie Daniels
Rankless by CCL
2026